VIVA LA THALOCAN! We’ve just heard from our Thalocan Research Innovations CEO Eric Zudak who is in attendance at the EADV Congress 2025 in Paris. He looks forward to sharing his insights and experiences regarding the latest science, research, and best practices across all areas of dermato-venereology. So much of what we offer here at Thalocan was and is inspired by past visits to EADV – it’s an essential platform for clinicians, researchers and industry professionals.